Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier.

about

Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier.

Item

http://www.wikidata.org/entity/Q52094378

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@en

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@nl

type

Item

label

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@en

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@nl

prefLabel

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@en

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@nl

P1476

Delivery of siRNA silencing P- ...... on at the blood-brain barrier.

@en

P2093

Patrick J Kennedy

http://www.w3.org/2001/XMLSchema#string

Susana Martins

http://www.w3.org/2001/XMLSchema#string

P2860

Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach

Ultrasound Microbubble Treatment Enhances Clathrin-Mediated Endocytosis and Fluid-Phase Uptake through Distinct Mechanisms

Structure and function of the blood-brain barrier

Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Modulation of p-glycoprotein function by caveolin-1 phosphorylation.

Functionalized silicon quantum dots tailored for targeted siRNA delivery.

Establishment of lipofection for studying miRNA function in human adipocytes.

Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.

Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.

Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers.

P31

scholarly article

P356

10.2217/NNM-2017-0023

http://www.w3.org/2001/XMLSchema#string

P50

Bruno Sarmento

Maria João Gomes

P577

2017-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28524759

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

nanoparticle